Intelligent Bio Solutions Current Ratio Growth & History (INBS)
Intelligent Bio Solutions's current ratio was 1.44 for fiscal 2026.
View full Intelligent Bio Solutions company overviewIntelligent Bio Solutions annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2026 | 2026-06-30 | 1.44 | 0.67 | +86.17% |
| 2025 | 2025-06-30 | 0.77 | −0.79 | −50.60% |
| 2024 | 2024-06-30 | 1.57 | 0.91 | +138.50% |
| 2023 | 2023-06-30 | 0.66 | −1.67 | −71.83% |
| 2022 | 2022-06-30 | 2.33 | −2.61 | −52.86% |
| 2021 | 2021-06-30 | 4.94 | 4.64 | +1524.90% |
| 2020 | 2020-06-30 | 0.30 | — | — |
Intelligent Bio Solutions quarterly current ratio
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q4 2026 | 2026-06-30 | 1.44 | 0.67 | +86.17% |
| Q3 2026 | 2026-03-31 | 2.11 | 1.00 | +88.96% |
| Q2 2026 | 2025-12-31 | 2.37 | 1.45 | +157.40% |
| Q1 2026 | 2025-09-30 | 0.89 | −0.26 | −22.35% |
| Q4 2025 | 2025-06-30 | 0.77 | −0.79 | −50.60% |
| Q3 2025 | 2025-03-31 | 1.12 | −0.90 | −44.58% |
| Q2 2025 | 2024-12-31 | 0.92 | 0.35 | +62.37% |
| Q1 2025 | 2024-09-30 | 1.14 | 0.75 | +190.15% |
| Q4 2024 | 2024-06-30 | 1.57 | 0.91 | +138.50% |
| Q3 2024 | 2024-03-31 | 2.02 | 0.77 | +61.40% |
| Q2 2024 | 2023-12-31 | 0.57 | −0.76 | −57.11% |
| Q1 2024 | 2023-09-30 | 0.39 | −3.09 | −88.71% |
| Q4 2023 | 2023-06-30 | 0.66 | −1.67 | −71.83% |
| Q3 2023 | 2023-03-31 | 1.25 | −1.65 | −56.91% |
| Q2 2023 | 2022-12-31 | 1.32 | −2.19 | −62.29% |
| Q1 2023 | 2022-09-30 | 3.48 | −2.12 | −37.81% |
| Q4 2022 | 2022-06-30 | 2.33 | −2.61 | −52.86% |
| Q3 2022 | 2022-03-31 | 2.90 | −7.74 | −72.71% |
| Q2 2022 | 2021-12-31 | 3.51 | −13.60 | −79.48% |
| Q1 2022 | 2021-09-30 | 5.60 | — | — |
| Q4 2021 | 2021-06-30 | 4.94 | 4.64 | +1524.90% |
| Q3 2021 | 2021-03-31 | 10.64 | — | — |
| Q2 2021 | 2020-12-31 | 17.12 | — | — |
| Q4 2020 | 2020-06-30 | 0.30 | — | — |
Intelligent Bio Solutions current ratio trends
Over the last five fiscal years, Intelligent Bio Solutions's current ratio decreased from 4.94 to 1.44, a change of −3.50. The latest reported quarter, Q4 2026, shows 1.44.
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Intelligent Bio Solutions source filings ↗